Some cancers and chronic inflammatory diseases are treated with immunotherapies. These stimulate the patient's immune system to recognize and destroy tumor cells. To improve such therapies, researchers are looking for mechanisms ...
Jun 19, 2025
0
43
A Peter Mac-initiated clinical trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma, who otherwise have a 50% chance of cure from conventional therapy.
Jun 19, 2025
0
0
Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer immunotherapy drugs. The findings may help unlock the full potential of TcEs and revolutionize cancer treatment ...
Jun 19, 2025
0
21
